Pregabalin API Market Size will reach to 1,276 mt in 2024

    Pregabalin is a drug used to treat epilepsy, neuropathic pain associated with diabetic peripheral neuropathy, herpes zoster sequelae neuropathic pain, fibromyalgia, neuropathic pain associated with bone marrow injury. It is first introduced by Pfizer under Lyrica brand in 2004.  Pregabalin active pharmaceutical ingredient (API) is used to produce finished drug including pregabalin capsule, pregabalin solution and pregabalin tablet.

    This report cover the pregabalin industrial chain based on API. Following are the industrial chain structure:

Source: HDIN Research

    The global anti-epileptic drugs market size was about 19.5 billion USD and the pregabalin finished product market size was 8.4 billion USD in 2018 according IMS data. The market share of pregabalin in anti-epileptic drugs exceed 43%. Global pregabalin API market volume was estimated at 822 metric ton (mt) in 2018 and is forecasted to reach 1,276 mt in 2024, with a CAGR of 7.6% according to HDIN Research data.

Source: HDIN Research

    There are 11 pregabalin API producers investigated in the report including Cipla, Mylan, Hetero,Laurus Lab, Sun Pharma, Chengdu Brilliant Pharmaceutical Group, CTTQ PHARMA etc. The report also investigate end user of pregabalin API such as Pfizer, Dr. Reddy's Laboratories, Sun Pharma, TEVA, Mylan etc.